(Q43868970)

English

Approach to dual-acting platelet activating factor (PAF) receptor antagonist/thromboxane synthase inhibitor (TxSI) based on the link of PAF antagonists and TxSIs

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Approach to dual-acting platelet activating factor (PAF) receptor antagonist/thromboxane synthase inhibitor (TxSI) based on the link of PAF antagonists and TxSIs (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Masakazu Fujita

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Taketsugu Seki

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Haruaki Inada

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kazuhiro Shimizu

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Akane Takahama

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Tetsuro Sano

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Bioorganic & Medicinal Chemistry Letters

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

341-344

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Is there a case for PAF antagonists in the treatment of ischemic states?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900731-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of platelet-activating factor in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900731-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet-activating factor and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900731-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900731-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical implications of prostaglandin and thromboxane A2 formation (1).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900731-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet activation in unstable coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900731-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900731-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-Activity Studies on Triazolothienodiazepine Derivatives as Platelet-Activating Factor Antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900731-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Thromboxane synthetase inhibitors (TXSI). Design, synthesis, and evaluation of a novel series of omega-pyridylalkenoic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900731-4

7 January 2021

based on heuristic

inferred from DOI database lookup

1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900731-4

7 January 2021

based on heuristic

inferred from DOI database lookup

CV-3988 - a specific antagonist of platelet activating factor (PAF)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900731-4

7 January 2021

based on heuristic

inferred from DOI database lookup

CV-4151--a potent, selective thromboxane A2 synthetase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900731-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0960-894X(01)00731-4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43868970&oldid=2104044218"